COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL

Conditions

Covid19, Rheumatic Diseases

Brief summary

The COVID-19 pandemic represents a threat to rheumatology patients. National advice for patients to 'shield' is based on risk stratification of therapies and other risk factors. While the epidemiology of COVID-19 in the rheumatological population is largely unknown large case registries are beginning to show potential drug treatment interactions. Strict self-isolation (shielding) has been recommended for those deemed 'high risk' although its impact on the likelihood of COVID-19 infection and health related quality of life (HRQoL) is unclear. The study aims to explore how this unprecedented situation has impacted the Trust patients primarily evaluating prevalence of the infection, effect of stringent social distancing (shielding) and Quality of Life (QOL). This will be done via a voluntary questionnaire, sent via text messaging at 6 and 12 months.

Natasha Cox, James Bateman

Lara D. Veeken2023-04-01

10.1093/rheumatology/kead104.098

The impact of the COVID-19 pandemic and stringent social distancing measures on health-related quality of life and COVID-19 infection rates in patients with rheumatic disease: a longitudinal analysis through the pandemic

Natasha Cox, Sabrina Raizada, Nick Barkham, Srinivasan Venkatachalam, Tom P Sheeran et al. (10 authors)

Rheumatology Advances in Practice2022-12-302 citations

10.1093/rap/rkad009

P075 Long COVID is associated with poor mental health in patients with rheumatic disease: results from a 14-month longitudinal study

Natasha Cox, Sabrina Raizada, Nick Barkham, James Bateman

Lara D. Veeken2022-04-231 citations

10.1093/rheumatology/keac133.074

P076 Innovative SMS based COVID-19 vaccination video advice: real-world evidence of the positive impact on vaccination uptake in a large single-centre cohort

Harsh Khatri, Natasha Cox, Lavanya Rajagopala, James Bateman

Lara D. Veeken2022-04-231 citations

10.1093/rheumatology/keac133.075

Interventions

OTHERQuestionnaire

Questionnaire to be completed at 6 and 12 months

Study design

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

* All rheumatology patients under active follow up at the Royal Wolverhampton Trust with a validated mobile telephone number

Exclusion criteria

* Patients without a validated mobile phone number linked to their hospital record

Design outcomes

Primary

Measure	Time frame	Description
Prevalence of COVID 19	1 year	percentage of cases
Mortality rates from COVID 19	1 year	number of deaths per 1000 individuals
Health related quality of life - Short Form 12	1 year	mental and physical component scores through patient reported outcomes. Normative score set at 50 with minimum score being 0 and maximum score being 100. Scores \>50 indicate better mental or physical health than the mean. Scores \<50 indicate worse mental or physical health than the mean

Countries

United Kingdom

Outcome results

None listed